Stereotaxis, Inc.

Stereotaxis, Inc. - ROEverified

STXS

Price:

$1.88

Market Cap:

$183.74M

Stereotaxis, Inc. specializes in the development, manufacturing, and commercialization of robotic systems, specialized instruments, and information management solutions for interventional laboratories, serving both domestic and international markets. A cornerstone of their product portfolio is their robotic magnetic navigation (RMN) technology, embodied by the Genesis RMN and Niobe systems. These innovative platforms empower clinicians to perform intricate interventional procedures by precisely guiding catheters and guidewires, under image guidance, through the vasculature and heart chambers to specific treatment sites. The company further delivers Odyssey, an advanced real-time information ...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2004-08-12

Stock Exchange

AMEX

Ticker

STXS

The ROE as of June 2026 (TTM) for Stereotaxis, Inc. (STXS) is -153.21%

According to Stereotaxis, Inc.’s latest financial reports and current stock price. The company's current ROE is -153.21%. This represents a change of 255.99% compared to the average of -43.04% of the last 4 quarters.

Stereotaxis, Inc. (STXS) Historical ROE (quarterly & annually)

How has STXS ROE performed in the past?

The mean historical ROE of Stereotaxis, Inc. over the last ten years is -47.33%. The current -153.21% ROE has changed 223.70% with respect to the historical average. Over the past ten years (40 quarters), STXS's ROE was at its highest in in the September 2016 quarter at 28.95%. The ROE was at its lowest in in the March 2025 quarter at -71.22%.

Quarterly (TTM)
Annual

Average

-47.33%

Median

-21.85%

Minimum

-210.33%

Maximum

34.04%

Stereotaxis, Inc. (STXS) ROE by Quarter and Year

Discovering the peaks and valleys of Stereotaxis, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 122.59%

Maximum Annual ROE = 34.04%

Minimum Annual Increase = -1102.46%

Minimum Annual ROE = -210.33%

Quarterly (TTM)
Annual
YearROEChange
2025-115.61%-45.04%
2024-210.33%122.59%
2023-94.49%64.94%
2022-57.29%110.77%
2021-27.18%64.52%
2020-16.52%2.64%
2019-16.10%-1102.46%
20181.61%-94.38%
201728.57%-16.08%
201634.04%-18.39%

Stereotaxis, Inc. (STXS) Average ROE

How has STXS ROE performed in the past?

The current ROE of Stereotaxis, Inc. (STXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-140.14%

5-year avg

-100.98%

10-year avg

-47.33%

Stereotaxis, Inc. (STXS) ROE vs. Peers

How is STXS’s ROE compared to its peers?

Stereotaxis, Inc.’s ROE is greater than Sanara MedTech Inc. (-246.44%), greater than NeoGenomics, Inc. (-11.82%), greater than Exagen Inc. (-113.53%), less than MDxHealth S.A. (402.97%), greater than Quanterix Corporation (-35.17%), greater than Arcturus Therapeutics Holdings Inc. (-36.55%), greater than Humacyte, Inc. (-2781.56%), greater than Sagimet Biosciences Inc. (-37.57%), greater than CVRx, Inc. (-120.77%), greater than OraSure Technologies, Inc. (-21.50%),

CompanyROEMarket cap
-246.44%$201.79M
-11.82%$289.85M
-113.53%$109.69M
402.97%$27.89M
-35.17%$159.69M
-36.55%$214.03M
-2781.56%$155.30M
-37.57%$217.65M
-120.77%$131.35M
-21.50%$292.61M

Build a custom stock screener for Stereotaxis, Inc. (STXS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Stereotaxis, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Stereotaxis, Inc. (STXS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Stereotaxis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Stereotaxis, Inc.'s ROE?

How is the ROE calculated for Stereotaxis, Inc. (STXS)?

What is the highest ROE for Stereotaxis, Inc. (STXS)?

What is the 3-year average ROE for Stereotaxis, Inc. (STXS)?

What is the 5-year average ROE for Stereotaxis, Inc. (STXS)?

How does the current ROE for Stereotaxis, Inc. (STXS) compare to its historical average?